China Universal Asset Management »

Humacyte shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $62k 20k 3.12
2023-12-31 $34k 12k 2.84
2023-09-30 $8.0k 2.7k 3.01
2023-06-30 $4.0k 1.4k 2.95
2023-03-31 $4.0k 1.4k 2.86
2022-12-31 $2.0k 1.0k 1.91
2022-09-30 $3.0k 965 3.11

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Humacyte

Vanguard Group
Millennium Management
Prescott General Partners
Charles Schwab Investment Management
Two Sigma Investments
Private Advisor
Capstone Investment Advisors
Citadel Advisors
Lion Point Capital
United Asset Strategies
GSA Capital Partners
Marshall Wace
Bank of New York Mellon
Clough Capital Partners
Goldman Sachs Group

View all funds holding Humacyte